Capres 150 mg Tablet

Capres 150 mg Tablet is used to treat breast, colon and stomach cancer. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs.

Capres 150 mg Tablet contains Capecitabine. When taken, it gets converted into 5-fluorouracil (chemical), which hampers the synthesis of genetic materials (DNA) in the cancer cells, thereby interfering with their growth.

Common side effects of Capres 150 mg Tablet include nausea, vomiting, weakness, loss of appetite, increased risk of infection, hair loss, diarrhoea, mouth ulcers, and blisters on fingers/feet in some cases. Most of these side effects do not require medical attention. However, talk to your doctor if these side effects persist.

Before taking Capres 150 mg Tablet, inform your doctor if you are allergic to it or any other medicine. Inform your doctor if you are pregnant as Capres 150 mg Tablet can cause harmful effects on the unborn baby. Both women and men using Capres 150 mg Tablet should use birth control to avoid pregnancy. You should not take Capres 150 mg Tablet during breastfeeding. Use Capres 150 mg Tablet with caution in elderly patients.

Capres 150 mg Tablet is used in the treatment of Breast cancer, stomach, rectal, and colon cancer. The detailed uses of Capres 150 mg Tablet are as follows:

• Colorectal Cancer: Capres 150 mg Tablet is used alone or with other drugs to treat colon and rectal cancers.
• Breast Cancer: Capres 150 mg Tablet is used especially for metastatic breast cancer or when other treatments have failed.
• Gastric (Stomach): Capres 150 mg Tablet is used in the treatment of Gastric (Stomach) cancer.
• Esophageal & Gastroesophageal Junction (GEJ) Cancer: Capres 150 mg Tablet is used in advanced or metastatic cases.
• Pancreatic Adenocarcinoma: Capres 150 mg Tablet is used post-surgery to reduce recurrence risk.

• Capres 150 mg Tablet should be taken within 30 minutes after a meal.
• It is recommended to take Capres 150 mg Tablet twice daily or as advised by your doctor.
• Swallow Capres 150 mg Tablet as a whole with a glass of water.
• Do not crush, chew, or break it.

• Capres 150 mg Tablet belongs to the group of anti-cancer medicines.
• It contains capecitabine, which is cytotoxic (causes cell death).
• It is used to treat cancer of the colon, breast and stomach. 
• When taken, it gets converted into 5-fluorouracil (chemical), which hampers the synthesis of genetic materials (DNA) in the cancer cells, thereby interfering with their growth.
• As a result, the growth of cancer cells is slowed down, and eventually, they are killed.

• Before taking Capres 150 mg Tablet, inform your doctor if you have any infection because Capres 150 mg Tablet may worsen the infection.
• If you have any allergy symptoms, talk to your doctor; inform your doctor if you have a DPD (dihydropyrimidine dehydrogenase deficiency), heart problems, bone marrow depression, kidney disease, liver disease, and treatment with chemotherapy or radiation.
• Some patients may experience increased sensitivity to light while taking Capres 150 mg Tablet, and avoiding prolonged exposure to sunlight is recommended.
• Consult your doctor if you are pregnant as Capres 150 mg Tablet can cause harmful effects on the unborn baby.
• Both women and men using Capres 150 mg Tablet should use birth control to avoid pregnancy.
• The use of Capres 150 mg Tablet by either parent may result in congenital disabilities.
• You should not take Capres 150 mg Tablet during breastfeeding.
• Use Capres 150 mg Tablet with caution in elderly patients.
• If you have had leukaemia (blood cancer) and are in remission, do not take live vaccines for three months after your last chemotherapy.
• You and your surrounding people, such as family members, should not take the polio vaccine.
• Avoid smoking or going near naked flames as the fabric (bedding, clothing, dressings) in contact with Capres 150 mg Tablet catches fire and burns easily.
• Washing clothing and bedding may reduce product build-up but not remove it.